Press Release

CEPI awards contract worth up to US$12.5 million to develop a human vaccine against Rift Valley fever

Wageningen Bioveterinary Research (WBVR), part of Wageningen University & Research, and the Coalition for Epidemic Preparedness Innovations (CEPI) hereby announce a new partnering agreement. With support from the European Union’s (EU’s) Horizon 2020 programme, CEPI will provide up to US$12.5 million for vaccine manufacturing, preclinical research, and a phase 1 study to assess the safety, tolerability, and immunogenicity of a single-dose vaccine candidate (RVFV-4s) against Rift Valley fever virus for use in humans. WBVR will lead a consortium of research, manufacturing, and clinical evaluation organisations to undertake this project.

Read more

10 million for One Health research in the Netherlands

Rotterdam, 12 June 2019 – Coming five years, Erasmus MC, together with partners from the Netherlands Centre for One Health, will investigate how the Netherlands can be better prepared for infectious diseases transmitted by mosquitoes. The Dutch Research Council (NWO) has awarded almost 9 million euros for this research. This amount has been supplemented to 10 million euros in contributions from seven collaborating public organisations. The multidisciplinary character of the collaboration, in which citizen science will play a role, is unique.

Read more